Mona V Dalal, MD
Family Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dalal’s office at (408) 274-7100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A138303 · Current
Licensed to practise in California · since 2015 · expires 2026-12-31 · University of Iowa Roy J. and Lucille A. Carver College of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$148,912 in 2024
Medicaid paid $148,912 for 1,829 billed services this clinician did in 2024, up to 56 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 445 | $148,137 |
| Short return visit (20+ min) | 336 | $374 |
| Return visit (30+ min) | 160 | $252 |
| Long return visit (40+ min) | 18 | $149 |
| Pain severity quantified; pain present (COA) (ONC) | 17 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 36 | $0 |
| Medication list documented in medical record (COA) | 252 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 129 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 191 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 19 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 111 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 93 | $0 |
| 2024 | 1,829 | 13 | 56 | $148,912 |
| 2023 | 601 | 5 | 38 | $97,931 |
| 2022 | 1,086 | 9 | 43 | $148,300 |
| 2021 | 768 | 5 | 42 | $147,187 |
| 2020 | 632 | 5 | 45 | $104,444 |
| 2018 | 52,518 | 42 | 489 | $2,238,015 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 303 | $96,537 |
| Long return visit (40+ min) | 67 | $721 |
| Short return visit (20+ min) | 168 | $416 |
| Return visit (30+ min) | 43 | $258 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 20 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 426 | $144,300 |
| Long return visit (40+ min) | 367 | $3,324 |
| Return visit (30+ min) | 59 | $435 |
| Short return visit (20+ min) | 86 | $241 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 26 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 60 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 33 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 16 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 427 | $145,876 |
| Long return visit (40+ min) | 131 | $1,086 |
| Return visit (30+ min) | 45 | $122 |
| Short return visit (20+ min) | 115 | $104 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 50 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 357 | $103,990 |
| Return visit (30+ min) | 67 | $203 |
| Short return visit (20+ min) | 166 | $102 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 14 | $88 |
| Short return visit | 28 | $62 |
2018
| Short return visit (20+ min) | 3,223 | $292,903 |
| Return visit (30+ min) | 1,638 | $223,410 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 307 | $218,271 |
| Contraceptive pills for bc | 2,022 | $187,068 |
| Unclassified drugs | 6,076 | $182,863 |
| OFF/OP EST MAY X REQ PHY/QHP | 3,635 | $133,666 |
| Contraceptive supply, hormone containing patch, each | 194 | $128,053 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 5,113 | $117,293 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 5,112 | $116,551 |
| OFFICE/OUTPATIENT VISIT NEW | 1,189 | $114,495 |
| Short return visit | 1,430 | $111,402 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 500 | $71,468 |
Drugs they prescribed that Part D paid
$32,158
Pharmacies billed $32,158 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (12 of 233) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
195 generic and 38 brand-name prescriptions · $32,158 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine-Naloxone | 14 | $3,107 | $222 |
| Gabapentin | 26 | $275 | $11 |
| Ibuprofen | 13 | $58 | $4 |
| Atorvastatin | 13 | $53 | $4 |
Year by year
| 2024 | 233 | 48 | 5% (12) | 16% | $32,158 |
| 2023 | 145 | 34 | None | None | $37,775 |
| 2022 | 110 | 30 | None | 26% | $36,237 |
| 2021 | 148 | 48 | None | 30% | $30,482 |
| 2020 | 164 | 54 | None | 18% | $13,973 |
| 2019 | 415 | 64 | 0% (0) | None | $15,700 |
| 2018 | 703 | 94 | 3% (22) | None | $31,018 |
| 2017 | 440 | 73 | None | None | $21,189 |
| 2016 | 217 | 103 | 7% (14) | 22% | $14,445 |
| 2015 | 50 | 34 | 0% (0) | 30% | $2,113 |
| 2014 | 48 | 24 | None | 27% | $1,107 |
| 2013 | 555 | 47 | 0% (0) | 31% | $33,792 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Descovy | 11 | $26,363 | $2,397 |
| Buprenorphine-Naloxone | 25 | $3,604 | $144 |
| Amlodipine Besylate | 11 | $70 | $6 |
2022: 2 drugs
| Descovy | 12 | $27,157 | $2,263 |
| Atorvastatin | 12 | $138 | $11 |
2021: 1 drug
| Atorvastatin | 12 | $72 | $6 |
2020: 2 drugs
| Gabapentin | 15 | $169 | $11 |
| Amlodipine Besylate | 16 | $58 | $4 |
2019: 10 drugs
| Ventolin Hfa | 12 | $1,107 | $92 |
| Atorvastatin | 64 | $886 | $14 |
| Gabapentin | 19 | $461 | $24 |
| Metformin | 27 | $255 | $9 |
| Levothyroxine | 12 | $224 | $19 |
| Losartan | 16 | $145 | $9 |
| Amlodipine Besylate | 17 | $142 | $8 |
| Lisinopril | 17 | $128 | $8 |
| Metoprolol | 13 | $112 | $9 |
| Hydrochlorothiazide | 21 | $106 | $5 |
2018: 20 drugs
| Ventolin Hfa | 20 | $1,329 | $66 |
| Atorvastatin | 66 | $856 | $13 |
| Levothyroxine | 30 | $635 | $21 |
| Gabapentin | 24 | $545 | $23 |
| Losartan | 20 | $324 | $16 |
| Metformin | 33 | $278 | $8 |
| Clotrimazole | 11 | $224 | $20 |
| Naproxen | 18 | $216 | $12 |
| Amlodipine Besylate | 25 | $214 | $9 |
| Ranitidine | 18 | $203 | $11 |
| Benazepril | 16 | $201 | $13 |
| Metoprolol | 16 | $191 | $12 |
| Fosinopril | 13 | $189 | $15 |
| Fluticasone Propionate | 14 | $172 | $12 |
| Omeprazole | 18 | $171 | $10 |
| Lisinopril | 26 | $166 | $6 |
| Hydrochlorothiazide | 36 | $164 | $5 |
| Simvastatin | 23 | $129 | $6 |
| Glipizide | 18 | $100 | $6 |
| Atenolol | 11 | $62 | $6 |
2017: 11 drugs
| Ventolin Hfa | 11 | $532 | $48 |
| Atorvastatin | 35 | $461 | $13 |
| Gabapentin | 19 | $369 | $19 |
| Levothyroxine | 15 | $247 | $16 |
| Metformin | 16 | $182 | $11 |
| Omeprazole | 16 | $164 | $10 |
| Fluticasone Propionate | 15 | $149 | $10 |
| Lisinopril | 15 | $116 | $8 |
| Benazepril | 12 | $90 | $8 |
| Alendronate | 15 | $80 | $5 |
| Hydrochlorothiazide | 12 | $56 | $5 |
2016: 2 drugs
| Estrace | 13 | $3,991 | $307 |
| Fluconazole | 14 | $112 | $8 |
2013: 14 drugs
| Lantus Solostar | 17 | $6,241 | $367 |
| Crestor | 29 | $4,901 | $169 |
| Diovan | 16 | $2,529 | $158 |
| Omeprazole | 51 | $1,039 | $20 |
| Atorvastatin | 29 | $947 | $33 |
| Amlodipine Besylate | 41 | $327 | $8 |
| Pravastatin | 14 | $284 | $20 |
| Unifine Pentips | 12 | $269 | $22 |
| Chlorthalidone | 17 | $266 | $16 |
| Metformin | 26 | $160 | $6 |
| Lisinopril | 32 | $156 | $5 |
| Simvastatin | 18 | $137 | $8 |
| Levothyroxine | 14 | $134 | $10 |
| Ranitidine | 13 | $130 | $10 |
Money from drug and device companies
$55 in 2025
A payment is not proof that care is biased.
| Gilead Sciences | None | $55 | 3 payments
|
See all 3 published payments
| Gilead Sciences | Meals · 2025-06-09 | None | $21 |
| Gilead Sciences | Meals · 2025-05-06 | None | $19 |
| Gilead Sciences | Meals · 2025-05-01 | None | $16 |
Professional record
- NPI
- 1235456195
- Licence
- CA 138303California A138303: Current · expires 2026-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1691 the Alameda, San Jose, CA, 95126
- NPI first listed
- 2010-04-30
- NPI last updated
- 2017-01-17
This is when the NPI record was last certified, not a medical board exam.